Spironolactone Patent Expiration
Spironolactone is Used for managing edema in cirrhotic patients and treating heart failure with reduced ejection fraction to increase survival and reduce hospitalizations. It was first introduced by Pfizer Inc
Spironolactone Patents
Given below is the list of patents protecting Spironolactone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Carospir | US10493083 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US10624906 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US10660907 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US10888570 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US11389461 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US11395828 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US11491166 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US9757394 | Spironolactone aqueous formulations | Oct 28, 2036 | Cmp Dev Llc |
Spironolactone's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Spironolactone:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
